Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q3 2024 Earnings Call Transcript
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q3 2024 Earnings Call Transcript November 7, 2024Rigel Pharmaceuticals, Inc. beats earnings expectations.
Posts Tagged ‘NASDAQ:RIGL’
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q2 2024 Earnings Call Transcript
Operator: Greetings and welcome to Rigel Pharmaceutical's Financial Conference Call for the Second Quarter 2024. At this time, all participants are in a listen-only mode.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript
Operator: Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the First Quarter 2024. At this time, all participants are in a listen-only mode.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript
Operator: Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the Fourth Quarter and Full Year 2023.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Rigel Pharmaceuticals Financial Conference Call for the Third Quarter of 2023. At this time, all participants are in listen-only mode.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the Second Quarter of 2023.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the First Quarter of 2023.
12 Best Low-Priced Growth Stocks To Buy
The US stock market is showing signs of unprecedented resilience, defying expectations of several analysts and hedge fund managers, including the Big Short Michael Burry, who ...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to Rigel Pharmaceuticals Financial Conference Call for the Fourth Quarter and Year End 2022.
Hedge Funds Are Crazy About Rigel Pharmaceuticals, Inc. (RIGL)
In this article we are going to use hedge fund sentiment as a tool and determine whether Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is a good investment right now.
Hedge Funds Are Crazy About Rigel Pharmaceuticals, Inc. (RIGL)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need ...
Were Hedge Funds Right About Rigel Pharmaceuticals, Inc. (RIGL)?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Is RIGL A Good Stock To Buy Now According To Hedge Funds?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
Hedge Funds Are Piling Into Rigel Pharmaceuticals, Inc. (RIGL)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Is Rigel Pharmaceuticals, Inc. (RIGL) Going to Burn These Hedge Funds?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Is Rigel Pharmaceuticals, Inc. (RIGL) A Good Stock To Buy?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Hedge Funds Have Never Been Less Bullish On Rigel Pharmaceuticals, Inc. (RIGL)
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Here’s What Hedge Funds Think About Rigel Pharmaceuticals, Inc. (RIGL)
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Rigel Pharmaceuticals, Inc. (RIGL): Hedge Fund Sentiment Unchanged
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money...
Hedge Fund and Insider Trading News: John Paulson, EJF Capital, Starbucks Co. (SBUX), Chegg Inc (CHGG), Rigel Pharmaceuticals, Inc. (RIGL), and More
After almost a year of behind-the-scenes work, billionaire hedge-fund manager John Paulson has formed a coalition with 15 other investors aimed at curbing years of what his fund...
FGL Holdings (FG), Rigel Pharmaceuticals (RIGL), Kemper (KMPR): Top Insider Buys of the Past Week
September has seen a huge uptick in terms of insider buying activity, with the five most active days for insider purchasing this year all having fallen within the past two weeks...
Market Movers Today: Switch Inc (SWCH), Longfin Corp (LFIN), Cellectis SA (ADR) (CLLS), Adamas Pharmaceuticals Inc (ADMS), and More
What happened: Shares of Switch (NYSE:SWCH) have gotten crushed today, down by 16% as of 12:20 p.m. EDT, after the data center specialist reported fourth-quarter earnings.
15 Penny Stocks Poised To Explode According To Hedge Funds
Penny stocks are usually defined as shares of small companies that trade under $1 per share, although the SEC defines a penny stock as a security that trades under $5 per share...
Is Rigel Pharmaceuticals, Inc. (RIGL) Worthy of Your Portfolio?
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions...
Here’s Why These Stocks Are Trending Today
The US stock market opened higher today as investors digested a series of economic data, which is being closely watched ahead of the Federal Reserve’s FOMC meeting next week...
What The Latest Data Means For Rigel Pharmaceuticals, Inc. (RIGL)
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) just put out data from its lead pivotal, and the company is up close to 50% on the numbers.
What We’re Looking For From The Upcoming Rigel Pharmaceuticals, Inc. (RIGL) Data
Rigel Pharmaceuticals, Inc.
Most Popular Healthcare Stocks Under $5
Most securities that cost less than a dinner at a fast-food restaurant are considered to be too risky, with most intra-day traders or other investors usually avoiding these low...
Broadfin Capital Ups Position in Rigel Pharmaceuticals, Inc. (RIGL)
Kevin Kotler's Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed.
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
To the average investor, there are many methods market participants can use to analyze publicly traded companies.
Hedge Funds Are Crazy About Astex Pharmaceuticals, Inc. (ASTX)
In the 21st century investor’s toolkit, there are dozens of indicators shareholders can use to analyze publicly traded companies.
What Hedge Funds Think About Kythera Biopharmaceuticals Inc (KYTH)
To the average investor, there are tons of methods market participants can use to track publicly traded companies.
This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)
In the financial world, there are dozens of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.
Hedge Funds Are Buying Impax Laboratories Inc (IPXL)
At the moment, there are tons of indicators shareholders can use to analyze publicly traded companies.
Amgen, Inc. (AMGN), Astex Pharmaceuticals, Inc. (ASTX), Pharmacyclics, Inc. (PCYC): This Week in Biotech
With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Hedge Funds Aren’t Crazy About Rigel Pharmaceuticals, Inc. (RIGL) Anymore
In the eyes of many investors, hedge funds are seen as useless, outdated investment tools of a forgotten age.
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?
To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies.
Hedge Funds Are Buying Endocyte, Inc. (ECYT)
At the moment, there are plenty of metrics shareholders can use to watch Mr. Market. A pair of the best are hedge fund and insider trading activity.
Hedge Funds Are Betting On Kythera Biopharmaceuticals Inc (KYTH)
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) was in 10 hedge funds' portfolio at the end of March.
Here is What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)
Is Pacira Pharmaceuticals Inc (NASDAQ:PCRX) a superb investment right now? Hedge funds are in an optimistic mood.
Is Astex Pharmaceuticals, Inc. (ASTX) Going to Burn These Hedge Funds?
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) was in 16 hedge funds' portfolio at the end of March.
Arena Pharmaceuticals, Inc. (ARNA), Rigel Pharmaceuticals, Inc. (RIGL): This Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Rigel Pharmaceuticals, Inc. (RIGL), Synta Pharmaceuticals Corp. (SNTA): Three Horrendous Health-Care Stocks This Week
Many stocks encountered turbulence this week, but few were blown about like several biotech stocks.
Neurocrine Biosciences, Inc. (NBIX): Are Hedge Funds Right About This Stock?
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 16 hedge funds' portfolio at the end of the first quarter of 2013.
Hedge Funds Are Betting On Rigel Pharmaceuticals, Inc. (RIGL)
According to most shareholders, hedge funds are seen as unimportant, outdated investment vehicles of years past.
Edwards Lifesciences Corp (EW), Sarepta Therapeutics Inc (SRPT), Rigel Pharmaceuticals, Inc. (RIGL): April’s Unhealthiest Stocks
Leading health-care stocks have had a good start to the year, but all's not healthy in the world of medicine.
Hedge Funds Are Buying Aegerion Pharmaceuticals, Inc. (AEGR)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds' portfolio at the end of the fourth quarter of 2012.
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?: Impax Laboratories Inc (IPXL), Pacira Pharmaceuticals Inc (PCRX)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds' portfolio at the end of December.
